148546-91-2 Usage
Uses
Used in Medicinal Chemistry:
Tert-butyl 4-(5-amino-2-methoxyphenyl)piperazine-1-carboxylate is utilized as a precursor in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of potential drug candidates that can be tailored for specific therapeutic targets.
Used in Drug Development:
In the pharmaceutical industry, tert-butyl 4-(5-amino-2-methoxyphenyl)piperazine-1-carboxylate is used as a key intermediate in the creation of new medications. Its versatile chemical structure enables the design of molecules with specific binding affinities and activities, which can be optimized for treating a range of diseases and conditions.
Used in Research and Investigation:
tert-butyl 4-(5-amino-2-methoxyphenyl)piperazine-1-carboxylate serves as a valuable tool in scientific research, where it is used to study the interactions between molecules and biological targets. Its role in research is crucial for understanding the mechanisms of action and potential side effects of new drug candidates, thereby facilitating the advancement of pharmaceutical science.
Check Digit Verification of cas no
The CAS Registry Mumber 148546-91-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,5,4 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 148546-91:
(8*1)+(7*4)+(6*8)+(5*5)+(4*4)+(3*6)+(2*9)+(1*1)=162
162 % 10 = 2
So 148546-91-2 is a valid CAS Registry Number.
148546-91-2Relevant articles and documents
RADIOLABELED 5-HT6 LIGANDS
-
Paragraph 0198-0199, (2014/05/08)
Compounds of formula (I) are disclosed Compounds of formula (I) are useful in treating conditions and disorders prevented by or ameliorated by 5-HT6 receptor ligands. Radiolabeled compounds of formula (I) are also useful as diagnostic tools as
BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
-
Page/Page column 21, (2009/05/28)
The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. wherein R1 is hydrogen or methyl R2 is hydrogen or methyl R3 hydrogen, fluorine C1-C2 alkoxy or fluorinated C1-C2 alkoxy; R4 is hydrogen, C1-C4 alkyl or fluorinated C1-C4 alkyl; R5 is hydrogen, fluorine, C1-C2 alkyl fluorinated C1-C2 alkyl C1-C2 alkoxy or fluorinated C1-C2 alkoxy; and R6 is hydrogen, fluorine or chlorine.
